EPB0231 | Incidence and types of Adverse Drug Reactions to first-line antiretroviral therapy in Nigeria | E-poster | Antiretroviral therapies and clinical issues in adults |
EPB0232 | Prevalence and predictors of persistent low-level HIV viraemia among people receiving Dolutegravir-based antiretroviral therapy in Southern Nigeria | E-poster | Antiretroviral therapies and clinical issues in adults |
EPB0233 | Therapeutic monitoring of long-acting injectable rilpivirine using a rapid enzymatic assay | E-poster | Antiretroviral therapies and clinical issues in adults |
EPB0234 | Sustained viral load suppression among people living with HIV on Dolutegravir-based regimen in Southern Nigeria | E-poster | Antiretroviral therapies and clinical issues in adults |
OAB0104 | Pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed pregnant women with HIV | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
OAB0202 | Prior M184V/I and multiple prior virological failures have no impact on the efficacy of switching HIV+ adults to DTG/3TC through 96Wks in SOLAR-3D | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
OAB0204 | High rates of long-term HIV RNA re-suppression after virological failure on dolutegravir in the ADVANCE trial | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
OAB0205 | Lenacapavir oral bridging maintains efficacy with a similar safety profile when SC LEN cannot be administered | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
OALBX0102 | Doravirine/Islatravir (100mg/0.75mg) once daily compared to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as Initial HIV-1 treatment: 48 week results from a double-blind phase 3 trial | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
TUPEB01 | Association of antiretroviral therapies with adverse perinatal outcomes in pregnant women living with HIV: systematic review and meta-analysis | Poster exhibition | Antiretroviral therapies and clinical issues in adults |